Director/PDMR Shareholding

By

Regulatory News | 10 Apr, 2019

Updated : 14:02

RNS Number : 7615V
RSA Insurance Group PLC
10 April 2019
 

RSA Insurance Group plc

("the Company")

 

Transactions in shares by Persons Discharging Managerial Responsibility ("PDMRs")

 

Ordinary Shares of £1.00 each

 

10 April 2019

 

The Company announces the following changes to the interests of PDMRs in the Company's Ordinary Shares of £1.00 each ("Shares").

 

On 8 April 2019 (being the first trading day after the third anniversary of the grant) the nil cost Conditional Awards over Shares granted on 6 April 2016 under the terms of the RSA Performance Share Plan 2014 ("PSP") to the following PDMRs vested as shown in the table below.

 

Name

No. of Performance Shares vested

No. of Dividend Equivalent Shares on Performance Shares

No. of Bonus

Deferral Shares Vested

No. of Dividend Equivalent Shares on Bonus Deferral Shares

 

No. of

Shares sold to cover statutory deductions

Martin Thompson

0

0

7,617

742

 

4,489

Nathan Williams

19,765

1,925

6,838

666

 

13,764

 

·      Bonus Deferral Shares relate to awards made in respect of 2015 as part of the Annual Bonus Plan.

 

·      As disclosed in the Company's 2018 Annual Report and Accounts, Performance Shares vested at 73.8% following testing of Group underlying Return on Tangible Equity (ROTE), Relative Total Shareholder Return (TSR) and Business Review Scorecard factors.

 

·      The Dividend Equivalent Shares are added to the awards at vesting in accordance with the rules of the PSP and Directors' Remuneration Policy.

 

·      Shares sold to cover statutory deductions were sold at a price of £5.247999  per share on 8 April 2019.

 

·      Shares retained have been transferred to the Equatex nominee account operated by RSA as part of the share plan administration system.

 

·      A six month holding period applies to vested Performance & Deferred Bonus Shares and to the Dividend Equivalents for Nathan Williams. This holding period is under Danish regulation applicable to these grants.

 

 

 

 

The forms required under the EU Market Abuse Regulation follow.

 

 

1.

Details of PDMR / Closely Associated Person ("CAP")

a)

Name

Martin Thompson

b)

Position / status

CEO, Canada

c)

Initial notification / amendment

Initial Notification

2.

Details of the issuer

a)

Name

RSA Insurance Group plc

b)

LEI

549300HOGQ7E0TY86138

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary Shares of £1 each

ISIN: GB00BKKMKR23

b)

Nature of the transaction

Vesting of Vesting of Bonus Deferral Share award granted on 6 April 2016 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 (PSP).

c)

Price(s) and volume(s)

Price(s) per unit

Volume(s)

NIL

7,617

 

d)

Aggregated information

-     Aggregated volume

-     Price

 

 

7617

NIL

e)

Date of the transaction

8 April 2019

f)

Place of the transaction

XLON London Stock Exchange

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary Shares of £1 each

ISIN: GB00BKKMKR23

b)

Nature of the transaction

Vesting of Dividend Equivalent Share award granted as part of the Bonus Deferral Share award over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 (PSP) at nil cost and added to that award at vesting.

c)

Price(s) and volume(s)

Price(s) per unit

Volume(s)

NIL

742

 

d)

Aggregated information

-     Aggregated volume

-     Price

 

 

742

 

NIL

e)

Date of the transaction

8 April 2019

f)

Place of the transaction

XLON London Stock Exchange

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary Shares of £1 each

ISIN: GB00BKKMKR23

b)

Nature of the transaction

Sale of shares to cover statutory deductions on share awards vested on 6 April 2019 under the RSA Performance Share Plan 2014.

c)

Price(s) and volume(s)

Price(s) per unit

Volume(s)

£5.247999

4,489

 

d)

Aggregated information

-     Aggregated volume

-     Price

 

 

4,489

 

£5.247999

e)

Date of the transaction

8 April 2019

f)

Place of the transaction

 

XLON London Stock Exchange

 

1.

Details of PDMR / Closely Associated Person ("CAP")

a)

Name

Nathan Williams

b)

Position / status

Group Underwriting Director

c)

Initial notification / amendment

Initial Notification

2.

Details of the issuer

a)

Name

RSA Insurance Group plc

b)

LEI

549300HOGQ7E0TY86138

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary Shares of £1 each

ISIN: GB00BKKMKR23

b)

Nature of the transaction

Vesting of Performance Share award granted on 6 April 2016 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 (PSP).

c)

Price(s) and volume(s)

Price(s) per unit

Volume(s)

NIL

19,765

 

d)

Aggregated information

-     Aggregated volume

-     Price

 

 

19,765

 

NIL

e)

Date of the transaction

8 April 2019

f)

Place of the transaction

XLON London Stock Exchange

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary Shares of £1 each

ISIN: GB00BKKMKR23

b)

Nature of the transaction

Vesting of Dividend Equivalent Share award granted as part of the Performance Share award on 6 April 2016 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 (PSP) at nil cost and added to that award at vesting.

c)

Price(s) and volume(s)

Price(s) per unit

Volume(s)

NIL

1,925

 

d)

Aggregated information

-     Aggregated volume

-     Price

 

 

1,925

 

NIL

e)

Date of the transaction

8 April 2019

f)

Place of the transaction

XLON London Stock Exchange

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary Shares of £1 each

ISIN: GB00BKKMKR23

b)

Nature of the transaction

Vesting of Bonus Deferral Share award granted on 6 April 2016 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 (PSP).

c)

Price(s) and volume(s)

Price(s) per unit

Volume(s)

NIL

6,838

 

d)

Aggregated information

-     Aggregated volume

-     Price

 

 

6,838

 

NIL

e)

Date of the transaction

8 April 2019

f)

Place of the transaction

XLON London Stock Exchange

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary Shares of £1 each

ISIN: GB00BKKMKR23

b)

Nature of the transaction

Vesting of Dividend Equivalent Share award granted as part of the Bonus Deferral Share award on 6 April 2016 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 (PSP) at nil cost and added to that award at vesting.

c)

Price(s) and volume(s)

Price(s) per unit

Volume(s)

NIL

666

 

d)

Aggregated information

-     Aggregated volume

-     Price

 

 

666

 

NIL

e)

Date of the transaction

8 April 2019

f)

Place of the transaction

XLON London Stock Exchange

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary Shares of £1 each

ISIN: GB00BKKMKR23

b)

Nature of the transaction

Sale of shares to cover statutory deductions on share awards vested on 6 April 2019 under the RSA Performance Share Plan 2014.

c)

Price(s) and volume(s)

Price(s) per unit

Volume(s)

£5.247999

13,764

 

d)

Aggregated information

-     Aggregated volume

-     Price

 

 

 

13,764

 

£5.247999

 

 

e)

Date of the transaction

8 April 2019

f)

Place of the transaction

XLON London Stock Exchange

 

Enquiries to:

 

Charlotte Heiss, Group Chief Legal Officer and Company Secretary

RSA Insurance Group plc

Tel:  +44 (0) 20 7111 7000

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHMMGMDLGGGLZG

Last news